Alcon’s PATANASE® Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms

PhotoPhoto

Back to: News Release
U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)
U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)

Download Formats

Share This Photo

URL:

Smart Multimedia Gallery

U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)
U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)Photo

U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)

http://www.businesswire.com/multimedia/google/20080415006615/en/1606695
http://www.businesswire.com/multimedia/google/20080415006615/en/1606695Logo

Download Formats

More

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.